Northwest Biotherapeutics (NWBO) Debt Ratio (2016 - 2025)
Northwest Biotherapeutics (NWBO) has 16 years of Debt Ratio data on record, last reported at 0.55 in Q3 2025.
- For Q3 2025, Debt Ratio fell 45.99% year-over-year to 0.55; the TTM value through Sep 2025 reached 0.55, down 45.99%, while the annual FY2024 figure was 0.82, 22.34% down from the prior year.
- Debt Ratio reached 0.55 in Q3 2025 per NWBO's latest filing, down from 0.62 in the prior quarter.
- Across five years, Debt Ratio topped out at 12.0 in Q2 2021 and bottomed at 0.29 in Q1 2025.
- Average Debt Ratio over 5 years is 2.73, with a median of 0.89 recorded in 2022.
- Peak YoY movement for Debt Ratio: soared 1572.14% in 2021, then crashed 92.77% in 2022.
- A 5-year view of Debt Ratio shows it stood at 3.29 in 2021, then dropped by 15.9% to 2.76 in 2022, then tumbled by 61.69% to 1.06 in 2023, then dropped by 22.34% to 0.82 in 2024, then tumbled by 33.03% to 0.55 in 2025.
- Per Business Quant database, its latest 3 readings for Debt Ratio were 0.55 in Q3 2025, 0.62 in Q2 2025, and 0.29 in Q1 2025.